Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Link Medical Products (LMP) is a specialist medical technology and pharmaceutical company that operates as a key commercialization partner in the Asia-Pacific and African regions. Originally part of the Link Healthcare group, the company was acquired by Clinigen in 2015 to bolster its global footprint in specialist medicine and medtech distribution. LMP is notably the exclusive distributor for Waldemar Link's orthopedic portfolio in its core territories, while also managing a diverse range of niche pharmaceutical products. The company's business model focuses on bridging the gap between global manufacturers and regional healthcare markets through regulatory, medical, and commercial expertise. Today, it operates as an integral part of Clinigen's international infrastructure, supporting the supply of both licensed and unlicensed medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Link Medical Products.